PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SAIA vs. LLY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SAIA and LLY is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

SAIA vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Saia, Inc. (SAIA) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
-0.74%
-15.94%
SAIA
LLY

Key characteristics

Sharpe Ratio

SAIA:

0.25

LLY:

0.52

Sortino Ratio

SAIA:

0.69

LLY:

0.93

Omega Ratio

SAIA:

1.10

LLY:

1.12

Calmar Ratio

SAIA:

0.32

LLY:

0.67

Martin Ratio

SAIA:

0.55

LLY:

1.67

Ulcer Index

SAIA:

23.08%

LLY:

9.68%

Daily Std Dev

SAIA:

51.82%

LLY:

31.10%

Max Drawdown

SAIA:

-80.35%

LLY:

-68.27%

Current Drawdown

SAIA:

-19.64%

LLY:

-24.28%

Fundamentals

Market Cap

SAIA:

$13.11B

LLY:

$652.65B

EPS

SAIA:

$13.83

LLY:

$9.29

PE Ratio

SAIA:

35.21

LLY:

78.12

PEG Ratio

SAIA:

2.44

LLY:

0.72

Total Revenue (TTM)

SAIA:

$2.42B

LLY:

$31.51B

Gross Profit (TTM)

SAIA:

$421.17M

LLY:

$25.63B

EBITDA (TTM)

SAIA:

$539.20M

LLY:

$9.48B

Returns By Period

In the year-to-date period, SAIA achieves a 6.84% return, which is significantly higher than LLY's -5.99% return. Over the past 10 years, SAIA has underperformed LLY with an annualized return of 26.04%, while LLY has yielded a comparatively higher 28.47% annualized return.


SAIA

YTD

6.84%

1M

-4.66%

6M

0.35%

1Y

10.27%

5Y*

38.04%

10Y*

26.04%

LLY

YTD

-5.99%

1M

-5.10%

6M

-15.11%

1Y

17.18%

5Y*

40.98%

10Y*

28.47%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SAIA vs. LLY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SAIA
The Risk-Adjusted Performance Rank of SAIA is 5555
Overall Rank
The Sharpe Ratio Rank of SAIA is 5555
Sharpe Ratio Rank
The Sortino Ratio Rank of SAIA is 5151
Sortino Ratio Rank
The Omega Ratio Rank of SAIA is 5353
Omega Ratio Rank
The Calmar Ratio Rank of SAIA is 6060
Calmar Ratio Rank
The Martin Ratio Rank of SAIA is 5353
Martin Ratio Rank

LLY
The Risk-Adjusted Performance Rank of LLY is 6363
Overall Rank
The Sharpe Ratio Rank of LLY is 6565
Sharpe Ratio Rank
The Sortino Ratio Rank of LLY is 5858
Sortino Ratio Rank
The Omega Ratio Rank of LLY is 5757
Omega Ratio Rank
The Calmar Ratio Rank of LLY is 7272
Calmar Ratio Rank
The Martin Ratio Rank of LLY is 6464
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SAIA vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Saia, Inc. (SAIA) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SAIA, currently valued at 0.25, compared to the broader market-2.000.002.004.000.250.52
The chart of Sortino ratio for SAIA, currently valued at 0.69, compared to the broader market-4.00-2.000.002.004.000.690.93
The chart of Omega ratio for SAIA, currently valued at 1.10, compared to the broader market0.501.001.502.001.101.12
The chart of Calmar ratio for SAIA, currently valued at 0.32, compared to the broader market0.002.004.006.000.320.67
The chart of Martin ratio for SAIA, currently valued at 0.55, compared to the broader market-10.000.0010.0020.0030.000.551.67
SAIA
LLY

The current SAIA Sharpe Ratio is 0.25, which is lower than the LLY Sharpe Ratio of 0.52. The chart below compares the historical Sharpe Ratios of SAIA and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
0.25
0.52
SAIA
LLY

Dividends

SAIA vs. LLY - Dividend Comparison

SAIA has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.72%.


TTM20242023202220212020201920182017201620152014
SAIA
Saia, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LLY
Eli Lilly and Company
0.72%0.67%0.78%1.07%1.23%1.75%1.96%1.95%2.46%2.77%2.37%2.84%

Drawdowns

SAIA vs. LLY - Drawdown Comparison

The maximum SAIA drawdown since its inception was -80.35%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for SAIA and LLY. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-19.64%
-24.28%
SAIA
LLY

Volatility

SAIA vs. LLY - Volatility Comparison

Saia, Inc. (SAIA) has a higher volatility of 11.54% compared to Eli Lilly and Company (LLY) at 10.25%. This indicates that SAIA's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%AugustSeptemberOctoberNovemberDecember2025
11.54%
10.25%
SAIA
LLY

Financials

SAIA vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Saia, Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab